한글목차

세계의 비침습적 혈당 모니터링 기기 시장은 2025년에 2,430만 달러에 달하고, 2032년까지 6,830만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 CAGR은 15.9%를 나타낼 전망입니다.

그림. 비침습적 혈당 모니터링 기기 시장 점유율(%), 지역별(2025년)

비침습적 혈당 모니터링은 인간의 조직에 손상을 주지 않으면서 혈당을 검출하는 것을 말합니다. 그리고 경제적이고 고통없는 혈당 모니터링 방법을 제공합니다. 이 기기는 채혈 대신 피부 근처의 혈관을 스캔하여 작동합니다. 광대역 레이더 등의 포도당 검출 기술의 개발에 의해 침습적인 모니터링 방법에 의한 측정치를 충실하게 반영할 수 있는 비침습적인 제품의 개발이 용이해졌습니다.

시장 역학 :

비침습적 혈당 모니터링 기기 시장은 세계의 당뇨병 유병률 증가와 지속적인 포도당 모니터링 기술의 진보에 의해 견인되고 있습니다. 고정밀도를 달성하기 위한 기술적 한계, 불충분한 임상적 검증, 규제 당국의 승인 지연 등의 요인이 여전히 보급을 억제하고 있습니다.

지식과 진단의 부족은 예측 기간 동안 세계의 비침습적 혈당 모니터링 기기 시장 성장을 방해할 것으로 예측됩니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 비침습적 혈당 모니터링 기기 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측기간(2025-2032년) 시장 규모 및 복합연간 성장률(CAGR%)을 제공합니다.
• 다양한 부문에 걸친 잠재적인 수익 성장 기회를 해명하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명하고 있습니다.
• 또한 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품의 출시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계의 비침습적 혈당 모니터링 기기 시장 주요 기업 프로파일을 제공합니다.
• 이 조사 보고서에서 다루는 주요 기업은 Baxter International Inc., Dexcom, Inc., Abbott, Medtronic, Senseonics Holdings, Inc., GlySens Incorporated, DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc. Inc., NovioSense BV, Quick LLC, RSP Systems A/S 등이 있습니다.
• 이 보고서로부터의 인사이트에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 발매, 유형 업, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
• 이 조사 보고서는 투자자, 공급업체, 제품 제조업체, 판매자, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자를 대상으로 합니다.
• 이해관계자는 세계의 비침습적 혈당 모니터링 기기 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정을 용이하게 할 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• 일관된 기회 맵(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
• 중증근무력증이나 수술 후 장폐색 등, 네오스티그민을 필요로 하는 질환의 이환율 상승
  • 성장 억제요인
• 지식과 진단의 부족
  • 기회
• 수의학의 성장
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• PORTER 분석
• 합병과 인수 시나리오

제4장 세계의 비침습적 혈당 모니터링 기기 시장 - 코로나바이러스(COVID-19) 유행의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 세계의 비침습적 혈당 모니터링 기기 시장, 기술별(2020-2032년)

• EM 파동
• 경피
• 광학
• 효소

제6장 세계의 비침습적 혈당 모니터링 기기 시장, 모달리티별(2020-2032년)

• 웨어러블
• 비웨어러블/벤치탑
• 임베디드 기기

제7장 세계의 비침습적 혈당 모니터링 기기 시장, 최종 사용자별(2020-2032년)

• 병원
• 클리닉
• 재택 케어 환경

제8장 세계의 비침습적 혈당 모니터링 기기 시장, 지역별(2020-2032년)

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제9장 경쟁 구도

• Baxter International Inc.
• Dexcom, Inc
• Abbott
• Medtronic
• Senseonics Holdings, Inc
• GlySens Incorporated
• DiaMonTech GmbH
• Nemaura Medical Inc.
• Integrity Applications, Inc.
• CNOGA Medical Ltd
• Breath Health, Inc.
• Metamaterial Technologies Inc.
• Opticology Inc.
• NovioSense BV
• Quick LLC
• RSP Systems A/S.

제10장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Global Non-Invasive Blood Glucose Monitoring Devices Market is estimated to be valued at USD 24.3 Mn in 2025 and is expected to reach USD 68.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 15.9% from 2025 to 2032.

Figure. Non-Invasive Blood Glucose Monitoring Devices Market Share (%), By Region 2025

Non-invasive blood glucose monitoring, as its name implies, refers to the detection of human blood glucose without causing damage to human tissues. Non-invasive blood glucose monitoring devices offer an economical and pain-free method to monitor blood glucose levels compared to traditional finger-pricking methods. These devices work by scanning the blood vessels near the skin instead of drawing blood. Advancement in glucose sensing technologies, such as minimally-invasive micro needles, near infrared spectroscopy, and ultra wideband radar, have facilitated the development of non-invasive products that can closely mirror readings from invasive monitoring methods. This provides diabetics with greater convenience and compliance in managing their condition. Non-invasive blood glucose monitoring devices can be segmented on the basis of technology into EM waves, transdermal, optical, and enzymatic.

Market Dynamics:

The non-invasive blood glucose monitoring devices market is driven by the growing prevalence of diabetes worldwide as well as advancements in continuous glucose monitoring technologies. Many new players are entering the market with novel solutions that can help overcome the challenges with existing invasive methods like finger pricks. However, factors such as technical limitations in achieving high accuracy compared to reference methods, insufficient clinical validation, and slow regulatory approvals continue to restrain widespread adoption. Nonetheless, continued R&D focusing on improved algorithms and sensors offers promising opportunities for non-invasive solutions to become a viable alternative to conventional glucose tests.

Lack of knowledge and diagnosis are expected to hamper the growth of the global non-invasive blood glucose monitoring devices market over the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global non-invasive blood glucose monitoring devices market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global non-invasive blood glucose monitoring devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Baxter International Inc., Dexcom, Inc, Abbott, Medtronic, Senseonics Holdings, Inc, GlySens Incorporated, DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global non-invasive blood glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global non-invasive blood glucose monitoring devices market

Detailed Segmentation:

• Global non-invasive blood glucose monitoring devices Market, By Technology:
  • EM Waves
  • Transdermal
  • Optical
  • Enzymatic
• Global non-invasive blood glucose monitoring devices Market, By Modality:
  • Wearable
  • Non-wearable/Benchtop
  • Embedded Devices
• Global non-invasive blood glucose monitoring devices Market, By End User:
  • Hospitals
  • Clinics
  • Homecare setting
• Global non-invasive blood glucose monitoring devices Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profile:
  • Baxter International Inc.
  • Dexcom, Inc
  • Abbott
  • Medtronic
  • Senseonics Holdings, Inc
  • GlySens Incorporated
  • DiaMonTech GmbH
  • Nemaura Medical Inc.
  • Integrity Applications, Inc.
  • CNOGA Medical Ltd.
  • Breath Health, Inc.
  • Metamaterial Technologies Inc.
  • Opticology Inc.
  • NovioSense BV
  • Quick LLC
  • RSP Systems A/S.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Technology
  • Market Snippet, By Modality
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Rising prevalence of diseases like myasthenia gravis and postoperative ileus requiring neostigmine
  • Restraints
• Lack of knowledge and diagnosis
  • Opportunities
• The growth of veterinary medicine
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Non-Invasive Blood Glucose Monitoring Devices Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• EM Waves
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Transdermal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Optical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Enzymatic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Modality, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Wearable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Non-wearable/Benchtop
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Embedded Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Non-Invasive Blood Glucose Monitoring Devices Market, By End User, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Homecare setting
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub Region, 2020-2032,(US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Baxter International Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Dexcom, Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Senseonics Holdings, Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlySens Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DiaMonTech GmbH
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nemaura Medical Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Integrity Applications, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CNOGA Medical Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Breath Health, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Metamaterial Technologies Inc.
• Opticology Inc.
• NovioSense BV
• Quick LLC
• RSP Systems A/S.
• Analyst Views

10. Section

• Research Methodology
• About us